Inhibition of hypoxia inducible factor 1α expression suppresses the progression of esophageal squamous cell carcinoma

Cancer Biology and Therapy

Volumn 11, Issue 11, 2011, Pages 981-987

  Zhu, Hong ^a   Feng, Yadong ^a   Zhang, Jie ^a   Zhou, Xiqiao ^a   Hao, Bo ^a   Zhang, Guoxin ^a   Shi, Ruihua ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Esophageal squamous cell carcinoma; Gene silencing; Hypoxia inducible factor 1 ; Proliferation; YC 1

Indexed keywords

GELATINASE A; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LIFICIGUAT; PROTEIN BCL 2; SHORT HAIRPIN RNA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PROTEIN DEPLETION; PROTEIN EXPRESSION; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INDAZOLES; MICE; MICE, NUDE; RNA INTERFERENCE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79957854018     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.11.11.15707     Document Type: Article

References (23)

1. Harris AL. Hypoxia-a key regulatory factor in tumour growth. Nature Rev Cancer 2002; 2:38-47. (Pubitemid 37328806)
2. Diaz-Gonzalez JA, Russell J, Rouzaut A, Gil-Bazo I, Montuenga L. Targeting hypoxia and angiogenesis through HIF-1alpha inhibition. Cancer Biol Ther 2005; 4:1055-62. (Pubitemid 41598557)
3. Binker MG, Binker-Cosen AA, Richards D, Gaisano HY, de Cosen RH, Cosen-Binker LI. Hypoxiareoxygenation increase invasiveness of PANC-1 cells through Rac1/MMP-2. Biochem Biophys Res Commun 2010; 393:371-6.
4. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, et al. Overexpression of hypoxiainducible factor1alpha in common human cancers and their metastases. Cancer Res 1999; 59:5830-5.
5. Baba M, Hirai S, Yamada-Okabe H, Hamada K, Tabuchi H, Kobayashi K, et al. Loss of von Hippel- Lindau protein causes cell density dependent deregulation of CyclinD1 expression through hypoxia-inducible factor. Oncogene 2003; 22:2728-38. (Pubitemid 36609588)
6. Kurokawa T, Miyamoto M, Kato K, Cho Y, Kawarada Y, Hida Y, et al. Overexpression of hypoxia-induciblefactor 1alpha(HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Br J Cancer 2003; 89:1042-7. (Pubitemid 37239209)
7. Katsuta M, Miyashita M, Makino H, Nomura T, Shinji S, Yamashita K, et al. Correlation of hypoxia inducible factor-1 alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer. Exp Mol Pathol 2005; 782:123-30. (Pubitemid 40248793)
8. Kimura S, Kitadai Y, Tanaka S, Kuwai T, Hihara J, Yoshida K, et al. Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human esophageal squamous cell carcinoma. Eur J Cancer 2004; 40:1904-12. (Pubitemid 39036767)
9. Yeo EJ, Chun YS, Cho YS, Kim J, Lee JC, Kim MS, et al. YC-1: a potential anticancer drug targeting hypoxiainducible factor 1. J Natl Cancer Inst 2003; 95:516-25. (Pubitemid 36511622)
10. Kim HL, Yeo EJ, Chun YS, Park JW. A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent. Int J Oncol 2006; 29:255-60.
11. Chan DA, Sutphin PD, Denko NC, Giaccia AJ. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J Biol Chem 2002; 277:40112-7. (Pubitemid 35191002)
12. Chan DA, Sutphin PD, Yen SE, Giaccia AJ. Coordinate regulation of the oxygendependent degradation domains of hypoxia-inducible factor a alpha. Mol Cell Biol 2005; 25:6415-26. (Pubitemid 41023218)
13. Semenza GL. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 2002; 8:62-7.
14. Yoshida D, Kim K, Noha M, Teramoto A. Antiapoptotic action by hypoxia inducible factor 1alpha in human pituitary adenoma cell line, HP-75 in hypoxic condition. J Neurooncol 2006; 78:217-25. (Pubitemid 44018814)
15. Liu XH, Yu EZ, Li YY, Kagan E. HIF-1alpha has an anti-apoptotic effect in human airway epithelium that is mediated via Mcl-1 gene expression. J Cell Biochem 2006; 97:755-65.
16. Li L, Lin X, Staver M, Shoemaker A, Semizarov D, Fesik SW, et al. Evaluating hypoxia-inducible factor- 1alpha as a cancer therapeutic target via inducible RNA interference in vivo. Cancer Res 2005; 65:7249-58. (Pubitemid 41161256)
17. Kimura S, Kitadai Y, Tanaka S, Kuwai T, Hihara J, Yoshida K, et al. Expression of hypoxia-inducible factor (HIF)-1 alpha is associated with vascular endothelial growth factor expression and tumor angiogenesis in human oesphageal squmaous cell carcinoma. Eur J Cancer 2004; 40:1904-12. (Pubitemid 39036767)
18. Kondo S, Kubota S, Shimo T, Nakanishi T, Sasaki A, Mese H, et al. Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 2002; 23:769-76. (Pubitemid 34567515)
19. Samantaray S, Sharma R, Chattopadhyaya TK, Gupta SD, Ralhan R. Increased expression of MMP2 and MMP9 in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2004; 130:37-44. (Pubitemid 38161246)
20. Greijer AE, van der Wall E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 2004; 57:1009-14. (Pubitemid 39331346)
21. Zhou J, Schmid T, Schnitzer S, Brune B. Tumor hypoxia and cancer progression. Cancer Lett 2006; 237:10-21.
22. Chen CJ, Hsu MH, Huang LJ, Yamori T, Chung JG, Lee FY, et al. Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI-H226. Biochem Pharmacol 2008; 75:360-8. (Pubitemid 350298460)
23. Lau CK, Yang ZF, Lam SP, Lam CT, Ngai P, Tam KH, et al. Inhibition of Stat3. activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma. Cancer Biol Ther 2007; 6:1900-7. (Pubitemid 351590402)